These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32811569)

  • 1. BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young.
    Tateishi K; Ikegaya N; Udaka N; Sasame J; Hayashi T; Miyake Y; Okabe T; Minamimoto R; Murata H; Utsunomiya D; Yamanaka S; Yamamoto T
    Acta Neuropathol Commun; 2020 Aug; 8(1):139. PubMed ID: 32811569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and cumulative analysis of clinical properties of BRAF V600E mutations in PLNTY histological samples.
    Baumgartner ME; Lang SS; Tucker AM; Madsen PJ; Storm PB; Kennedy BC
    Childs Nerv Syst; 2024 May; 40(5):1361-1366. PubMed ID: 38150037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphous low-grade neuroepithelial tumor of the young: case report and review focus on the radiological features and genetic alterations.
    Chen Y; Tian T; Guo X; Zhang F; Fan M; Jin H; Liu D
    BMC Neurol; 2020 Apr; 20(1):123. PubMed ID: 32252664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).
    Kakkar A; Majumdar A; Kumar A; Tripathi M; Pathak P; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
    Epilepsy Res; 2016 Nov; 127():141-151. PubMed ID: 27599148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of molecular subgroups of polymorphous low-grade neuroepithelial tumor of the young (PLNTY): A small single institutional case series and integrated analysis.
    Vuong HG; Alzayadneh E; Reith TP; Eschbacher KL
    Pathol Res Pract; 2023 Dec; 252():154922. PubMed ID: 37984047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A newly diagnosed case of polymorphous low-grade neuroepithelial tumor of the young.
    Bitar M; Danish SF; Rosenblum MK
    Clin Neuropathol; 2018; 37(4):178-181. PubMed ID: 29701169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric and elderly polymorphous low-grade neuroepithelial tumor of the young: Typical and unusual case reports and literature review.
    Furuta T; Moritsubo M; Muta H; Shimamoto H; Ohshima K; Sugita Y
    Neuropathology; 2023 Aug; 43(4):319-325. PubMed ID: 36545913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Analysis of Dysembryoplastic Neuroepithelial Tumor Spectrum Reveals a Diversity of Molecular Alterations Dysregulating the MAPK and PI3K/mTOR Pathways.
    Surrey LF; Jain P; Zhang B; Straka J; Zhao X; Harding BN; Resnick AC; Storm PB; Buccoliero AM; Genitori L; Li MM; Waanders AJ; Santi M
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1100-1111. PubMed ID: 31617914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation.
    Ida CM; Johnson DR; Nair AA; Davila J; Kollmeyer TM; Minn K; Fadra NM; Balcom JR; Fung KA; Kim DK; Kaufmann TJ; Kipp BR; Halling KC; Jenkins RB; Giannini C
    J Neuropathol Exp Neurol; 2021 Sep; 80(9):821-829. PubMed ID: 34363682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphous Low-Grade Neuroepithelial Tumor of the Young: A Case Report with Genomic Findings.
    Gupta VR; Giller C; Kolhe R; Forseen SE; Sharma S
    World Neurosurg; 2019 Dec; 132():347-355. PubMed ID: 31520766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
    Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
    J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional features of low-grade neuroepithelial tumors with the BRAF V600E mutation associated with epileptogenicity.
    Iijima K; Komatsu K; Miyashita S; Suyama K; Murayama K; Hashizume K; Tabe NK; Miyata H; Iwasaki M; Taya S; Hoshino M
    Genes Cells; 2024 Mar; 29(3):192-206. PubMed ID: 38269481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy-related protein expression was associated with BRAF V600E mutation in epilepsy associated glioneuronal tumors.
    Shen CH; Zhang YX; Xu JH; Zhu QB; Zhu JM; Guo Y; Ding Y; Wang S; Ding MP
    Epilepsy Res; 2017 Sep; 135():123-130. PubMed ID: 28667867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway.
    Huse JT; Snuderl M; Jones DT; Brathwaite CD; Altman N; Lavi E; Saffery R; Sexton-Oates A; Blumcke I; Capper D; Karajannis MA; Benayed R; Chavez L; Thomas C; Serrano J; Borsu L; Ladanyi M; Rosenblum MK
    Acta Neuropathol; 2017 Mar; 133(3):417-429. PubMed ID: 27812792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
    Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships between transporter expression and the status of BRAF V600E mutation and F-18 FDG uptake in papillary thyroid carcinomas.
    Yoon M; Jung SJ; Kim TH; Ha TK; Urm SH; Park JS; Lee SM; Bae SK
    Endocr Res; 2016; 41(1):64-9. PubMed ID: 26513490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THE RELATIONSHIP OF BRAF
    Santhanam P; Khthir R; Solnes LB; Ladenson PW
    Endocr Pract; 2018 Jan; 24(1):21-26. PubMed ID: 29144823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy response monitoring of the early effects of a new BRAF inhibitor on melanoma xenograft in mice: evaluation of (18) F-FDG-PET and (18) F-FLT-PET.
    Geven EJ; Evers S; Nayak TK; Bergström M; Su F; Gerrits D; Franssen GM; Boerman OC
    Contrast Media Mol Imaging; 2015; 10(3):203-10. PubMed ID: 25204436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study.
    Nagarajah J; Ho AL; Tuttle RM; Weber WA; Grewal RK
    J Nucl Med; 2015 May; 56(5):662-7. PubMed ID: 25814520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF V600E-mutated central nervous system tumor with divergent morphological feature - Anaplastic pleomorphic xanthoastrocytoma-like and astroblastoma-like.
    Purkait S; Bansal S; Malgulwar PB
    Neuropathology; 2019 Feb; 39(1):64-67. PubMed ID: 30557911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.